title: The link between intraneuronal N-truncated amyloid-β peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism.
abstract: BACKGROUND
  Autism is a neurodevelopmental disorder of unknown etiopathogenesis associated with structural and functional abnormalities of neurons and increased formation of reactive oxygen species. Our previous study revealed enhanced accumulation of amino-terminally truncated amyloid-β (Aβ) in brain neurons and glia in children and adults with autism. Verification of the hypothesis that intraneuronal Aβ may cause oxidative stress was the aim of this study.
  
  
  RESULTS
  The relationships between neuronal Aβ and oxidative stress markers-4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA)-were examined in the frontal cortex from individuals aged 7-32 years with idiopathic autism or with chromosome 15q11.2-q13 duplications (dup(15)) with autism, and age-matched controls. Quantification of confocal microscopy images revealed significantly higher levels of neuronal N-truncated Aβ and HNE and MDA in idiopathic autism and dup(15)/autism than in controls. Lipid peroxidation products were detected in all mitochondria and lipofuscin deposits, in numerous autophagic vacuoles and lysosomes, and in less than 5% of synapses. Neuronal Aβ was co-localized with HNE and MDA, and increased Aβ levels correlated with higher levels of HNE and MDA.
  
  
  CONCLUSIONS
  The results suggest a self-enhancing pathological process in autism that is initiated by intraneuronal deposition of N-truncated Aβ in childhood. The cascade of events includes altered APP metabolism and abnormal intracellular accumulation of N-terminally truncated Aβ which is a source of reactive oxygen species, which in turn increase the formation of lipid peroxidation products. The latter enhance Aβ deposition and sustain the cascade of changes contributing to metabolic and functional impairments of neurons in autism of an unknown etiology and caused by chromosome 15q11.2-q13 duplication.
authors.affiliation: Department of Developmental Neurobiology, NYS Institute for Basic Research in Developmental Disabilities, New York, Staten Island, USA. Janusz.Frackowiak@opwdd.ny.gov.
authors.forename: Janusz
authors.initials: J
authors.lastname: Frackowiak
authors.forename: Bozena
authors.initials: B
authors.lastname: Mazur-Kolecka
authors.forename: N Carolyn
authors.initials: NC
authors.lastname: Schanen
authors.forename: W Ted
authors.initials: WT
authors.lastname: Brown
authors.forename: Jerzy
authors.initials: J
authors.lastname: Wegiel
mesh_terms: D000293:Adolescent; D000328:Adult; D000447:Aldehydes / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D001321:Autistic Disorder / Q000150:complications / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D002648:Child; D002869:Chromosome Aberrations; D002884:Chromosomes, Human, Pair 15 / Q000378:metabolism; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000150:complications / Q000378:metabolism*; D015227:Lipid Peroxidation / Q000502:physiology; D008247:Lysosomes / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D013569:Synapses / Q000378:metabolism; D014617:Vacuoles / Q000378:metabolism; D055815:Young Adult
chemical_list: D000447:Aldehydes; D016229:Amyloid beta-Peptides; D008315:Malondialdehyde; C027576:4-hydroxy-2-nonenal